# Vectura Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vectura-group

- Industry: Pharmaceuticals
- Headquarters: UK
- Website: www.vectura.com
- Total disclosed funding: $18M
- Latest round: Series B (Apr 24, 2001)
- Investors on record: 4

## About

Based in Chippenham, UK, and founded in 1997, Vectura Group Plc operates as a developer of inhaled therapies for the treatment of respiratory diseases. As of 2021, the company employs around 450 employees and its CEO is Will Downie. In January 2025, Molex, LLC, a portfolio company of Koch Equity Development, acquired Vectura Group Plc. Financial terms of the transaction were not disclosed.

## Funding rounds

- Series B, Apr 24, 2001, $15M — Excalibur Fund Managers, Columbia Threadneedle Investments, Northern Ventures, University of Bath
- Series A, Feb 24, 1999, $2.8M — Excalibur Fund Managers
- Seed, Dec 1, 1997 — Excalibur Fund Managers

## Investors

- Excalibur Fund Managers (https://capitalatlas.ai/funds/excalibur-fund-managers) — Seed, Series A, Series B
- Columbia Threadneedle Investments — Series B
- Northern Ventures — Series B
- University of Bath — Series B